Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.

Details

Ressource 1Download: 32277236_BIB_8F1C1BE3C2E7.pdf (173.31 [Ko])
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_8F1C1BE3C2E7
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.
Journal
Neuro-oncology
Author(s)
Mohile N.A., Blakeley J.O., Gatson NTN, Hottinger A.F., Lassman A.B., Ney D.E., Olar A., Schiff D., Shih H.A., Strowd R., van den Bent M.J., Ziu M.
ISSN
1523-5866 (Electronic)
ISSN-L
1522-8517
Publication state
Published
Issued date
11/04/2020
Peer-reviewed
Oui
Volume
22
Number
7
Pages
912-17
Language
english
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Abstract
The COVID-19 outbreak is posing unprecedented risks and challenges for all communities and healthcare systems, worldwide. There are unique considerations for many adult patients with gliomas who are vulnerable to the novel coronavirus due to older age and immunosuppression. As patients with terminal illnesses, they present ethical challenges for centers that may need to ration access to ventilator care due to insufficient critical care capacity. It is urgent for the neuro-oncology community to develop a pro-active and coordinated approach to the care of adults with gliomas in order to provide them with the best possible oncologic care while also reducing their risk of viral infection during times of potential healthcare system failure. In this article, we present an approach developed by an international multi-disciplinary group to optimize the care of adults with gliomas during this pandemic. We recommend measures to promote strict social distancing and minimize exposures for patients, address risk and benefit of all therapeutic interventions, pro-actively develop end of life plans, educate patients and caregivers and ensure the health of the multi-disciplinary neuro-oncology workforce. This pandemic is already changing neuro-oncologic care delivery around the globe. It is important to highlight opportunities to maximize the benefit and minimize the risk of glioma management during this pandemic and potentially, in the future.
Keywords
Adult glioma, COVID-19, Pandemic
Pubmed
Web of science
Open Access
Yes
Create date
25/04/2020 21:26
Last modification date
07/07/2021 6:35
Usage data